Trade

Fortis Healthcare share price

Balanced risk
  • 26%Low risk
  • 26%Moderate risk
  • 26%Balanced risk
  • 26%High risk
  • 26%Extreme risk
  • 893.45(0.24%)
    February 10, 2026 15:10:07 PM IST
    • NSE
    • BSE
  • Vol : 892.40 K (NSE + BSE)
    Last 20 day avg : 1.84 M

Fortis Healthcare is trading 0.24% upper at Rs 893.45 as compared to its last closing price. Fortis Healthcare has been trading in the price range of 895.90 & 885.25. Fortis Healthcare has given 0.83% in this year & 6.37% in the last 5 days. Fortis Healthcare has TTM P/E ratio 72.24 as compared to the sector P/E of 26.16.There are 14 analysts who have initiated coverage on Fortis Healthcare. There are 2 analysts who have given it a strong buy rating & 8 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 321.92 Crores in its last quarter.Listed peers of Fortis Healthcare include Max Healthcare Institute (1.10%), Narayana Hrudayalaya (2.86%), Aster DM Healthcare (0.87%).The Mutual Fund holding in Fortis Healthcare was at 24.22% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Fortis Healthcare was at 27.84% in 31 Dec 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Feb 10, 2026, 09:40 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.13
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.28
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.12
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    7.25
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    63.74
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    5.44
    Indicates overvaluation
Price range
Day Range
Lowest
885.25
Highest
895.90
52 week range
Lowest
521.05
Highest
1,105.00
Fortis Healthcare Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Max Healthcare Institute
Neutral
1,021.001.1099,279.5493.4311.210.1429.50
Narayana Hrudayalaya
Moderately Bearish
1,795.052.8636,680.6447.6610.510.2459.03
Aster DM Healthcare
Neutral
576.800.8729,874.7786.958.680.8453.36
Global Health
Neutral
1,138.00-1.9530,519.9761.739.450.0418.41
Apollo Hospitals Enterprise
Neutral
7,222.000.151,03,841.2871.0912.560.2683.18
Mutual Fund Ownership
View all
Tata Nifty MidSmall Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 9.05
  • % of AUM 6.63
Motilal Oswal Nifty MidSmall Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 1.60
  • % of AUM 6.60
HDFC MNC Fund Regular Growth
NA
  • Amount Invested (Cr.) 36.53
  • % of AUM 6.25
Shriram Multi Sector Rotation Fund Regular Growth
NA
  • Amount Invested (Cr.) 11.53
  • % of AUM 5.92
WhiteOak Capital Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 16.99
  • % of AUM 5.12
Fortis Healthcare Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-13Quarterly Results
2025-11-11Quarterly Results
2025-08-06Quarterly Results & Others
2025-05-20Audited Results & Final Dividend
2025-02-07Quarterly Results
About the company Fortis Healthcare
  • IndustryHealthcare Facilities
  • ISININE061F01013
  • BSE Code532843
  • NSE CodeFORTIS
Fortis Healthcare Limited is an India-based integrated healthcare service provider. The Company is primarily engaged in the business of healthcare services. Its segment includes the Healthcare business and the Diagnostics business. The healthcare business includes inpatient and outpatient services, sale of medical and nonmedical items and management fees from hospitals. The diagnostic business includes pathology and radiology services. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. The healthcare verticals of the Company primarily consist of day care specialty, diagnostics and tertiary and quaternary care. The Company has approximately 28 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, the United Arab Emirates, Nepal, and Sri Lanka.
  • Management Info
  • Ashutosh RaghuvanshiChief Executive Officer, Managing Director, Executive Director
  • Vivek GoyalChief Financial Officer
  • Satyendra ChauhanCompliance Officer, Company Secretary
Fortis Healthcare Share Price FAQs

Fortis Healthcare is trading at 893.45 as on Tue Feb 10 2026 09:40:07. This is 0.24% upper as compared to its previous closing price of 891.35.

The market capitalization of Fortis Healthcare is 67402.58 Cr as on Tue Feb 10 2026 09:40:07.

The average broker rating on Fortis Healthcare is Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 8 analysts have given a buy rating
  • 4 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Fortis Healthcare is 1105.00 whereas the 52 wk low is 521.05

Fortis Healthcare can be analyzed on the following key metrics -

  • TTM P/E: 72.24
  • Sector P/E: 26.16
  • Dividend Yield: 0.11%
  • D/E ratio: 0.34

Fortis Healthcare reported a net profit of 774.22 Cr in 2025.

The Mutual Fund Shareholding was 24.22% at the end of 31 Dec 2025.